FLOT Regimen: 5-FU Infusion Duration for Gastroesophageal Junction Cancer
In the FLOT regimen for gastroesophageal junction cancer, 5-fluorouracil should be administered as a 24-hour continuous infusion at 2,600 mg/m² on day 1, following a 400 mg/m² IV bolus.
Standard FLOT Dosing Schedule
The FLOT regimen follows a 14-day (2-week) cycle with the following components administered on day 1:
- Docetaxel: 50 mg/m² IV
- Oxaliplatin: 85 mg/m² IV over 2 hours
- Leucovorin: 200-400 mg/m² IV over 2 hours
- 5-Fluorouracil:
The cycle repeats every 2 weeks, with 4 preoperative and 4 postoperative cycles recommended for perioperative treatment 1.
Key Infusion Details
The 5-FU continuous infusion runs for exactly 24 hours (not 46-48 hours as in FOLFOX/FOLFIRI regimens). This is a critical distinction from other fluoropyrimidine-based regimens 2, 3.
Some variations exist in the literature:
- The original phase II trial used 2,600 mg/m² over 24 hours 2
- Modified regimens in Chinese populations have used 2,200-2,400 mg/m² over 48 hours 4, 3
- The FLOT4 trial establishing FLOT as standard of care used 2,600 mg/m² as 24-hour infusion 1
Important Practical Considerations
Medication error prevention: Order the 5-FU as a 24-hour unit (2,600 mg/m²/day), not as a total dose over multiple days, to minimize prescribing errors 3.
Regional variations: North American patients may experience greater fluoropyrimidine toxicity than European patients, though the standard FLOT dose of 2,600 mg/m² over 24 hours remains the evidence-based recommendation 1.
Dose modifications: In patients experiencing significant toxicity, modified FLOT regimens have used lower 5-FU doses (2,200 mg/m²) with acceptable efficacy, though this represents a deviation from the standard regimen 4.
Clinical Context
The FLOT regimen has demonstrated superior overall survival compared to older regimens (ECF/ECX) in gastroesophageal junction adenocarcinoma, with the specific 24-hour 5-FU infusion schedule being integral to the regimen's efficacy and tolerability profile 1, 2. The biweekly schedule with 24-hour 5-FU infusion allows for better treatment intensity while maintaining an acceptable toxicity profile compared to 3-week regimens 2.